Optellum
Optellum develops an imaging biomarker for smart lung cancer detection.
Total raised
€16M
€15,677,268
Funding rounds
2
Investors
7
distinct backers
Active since
2019-06
latest 2022-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 10y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-27 | Series A | €15M | Black Opal Ventures,family office of Sir Martin & Lady Audrey Wood,Intuitive Ventures,IQ Capital,Mercia,St John’s College | View deal → |
| 2019-07-01 | Seed | €1.1M | Luminous Ventures | View deal → |